E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity

Rajiv Jash, Chiranjib Bagchi, Achintya Mitra, Santanu Kumar Tripathi.

Abstract
Background: Gugulipid obtained from Commiphora mukul carries a long history of safe and efficacious use in hyperlipidemia as per Ayurvedic literature. Statins like atorvastatin are a highly prescribed hypolipidemic drug but not free from potentially serious adverse effects.

Aims and Objectives: The present study was designed to establish antihyperlipidemic activity of gugulipid in triton-induced hyperlipidemic rats in comparison to atorvastatin and simultaneously to explore the combination of gugulipid and atorvastatin for any synergistic activity.

Materials and Methods: Male Wistar albino rats (20) were divided equally into vehicle (2% gum acacia) (Group I), gugulipid only 6.75 mg/kgbw (Group II), atorvastatin 7.2 mg/kgbw only (Group III), and gugulipid 6.75 mg/kgbw and atorvastatin in 7.2 mg/kgbw combination (Group IV) in Phase 1 study. In Phase 2, additional three groups were created with five rats in each receiving gugulipid 6.75 mg/kgbw with atorvastatin at 5.4 mg/kgbw, 3.6 mg/kgbw, and 1.8 mg/kgbw dosage, respectively (Groups V–VII). Hyperlipidemia was induced by single intraperitoneal injection (400 mg/kgbw) of triton after 7 days of feeding with respective agents dissolved in vehicle through oral route.

Results: Regarding total cholesterol (TC), triglyceride (TG), and low-density lipoprotein (LDL), Gr II was found superior to Gr I but inferior to others (P < 0.01). Gr IV prevented the rise of TC and TG significantly in comparison to Gr V, VI, and VII (P < 0.01) whereas Groups V and VI having non-significant difference in between, both differed significantly (P < 0.01) with Gr VII. Groups IV, V, and VI prevented the rise of serum LDL significantly (P < 0.01) from Group VII.

Conclusion: Gugulipid showed significant antihyperlipidemic activity and was found to be optimally efficacious and safe in combination with even reduced dose of atorvastatin.

Key words: Hypolipidemic; Antihyperlipidemic; Triton; Hyperlipidemic; Gugulipid; Atorvastatin; Drug Synergism


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Rajiv Jash
Articles by Chiranjib Bagchi
Articles by Achintya Mitra
Articles by Santanu Kumar Tripathi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. doi:10.5455/njppp.2022.12.08304202101092021


Web Style

Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. http://www.njppp.com/?mno=114616 [Access: November 30, 2021]. doi:10.5455/njppp.2022.12.08304202101092021


AMA (American Medical Association) Style

Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. doi:10.5455/njppp.2022.12.08304202101092021



Vancouver/ICMJE Style

Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. doi:10.5455/njppp.2022.12.08304202101092021



Harvard Style

Jash, R., Bagchi, . C., Mitra, . A. & Tripathi, . S. K. (2022) Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. doi:10.5455/njppp.2022.12.08304202101092021



Turabian Style

Jash, Rajiv, Chiranjib Bagchi, Achintya Mitra, and Santanu Kumar Tripathi. 2022. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. doi:10.5455/njppp.2022.12.08304202101092021



Chicago Style

Jash, Rajiv, Chiranjib Bagchi, Achintya Mitra, and Santanu Kumar Tripathi. "Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity." doi:10.5455/njppp.2022.12.08304202101092021



MLA (The Modern Language Association) Style

Jash, Rajiv, Chiranjib Bagchi, Achintya Mitra, and Santanu Kumar Tripathi. "Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity." doi:10.5455/njppp.2022.12.08304202101092021



APA (American Psychological Association) Style

Jash, R., Bagchi, . C., Mitra, . A. & Tripathi, . S. K. (2022) Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. doi:10.5455/njppp.2022.12.08304202101092021